June 7, 2021 8:04am

Key word: expectation amidst a trolly-ride of share pricing, the views can’t be beaten yet the dips are memorable

Are you ready: Annual Oncology Meetings begin this week?

Pre-open indications: 5 BUYs: and 3 Maintain SELL

My version of the morning’s “indications” is about what you need to know; it’s what could happen or materialize after the opening and what might happen during the session

Subscription is coming, it’s not conscription but, an offer to join our collective of like-minded investors!  

Dow futures are UP +0.12% (+42 points), S&P futures are DOWN -0.04% (-2 point) and NASDAQ futures are DOWN -0.18% (-25 points)

 

U.S. stock futures point to a lower open on Monday,

European stocks were slightly higher,

Asia-Pacific stocks closed mixed even as China’s exports in dollar terms rose 27.9% in May (versus last year)

 

Data Docket: inflation reading, May’s Consumer Price Index (CPI) on Thursday.

 

Henry’omics:

New week, another set of hurdles …

The S&P 500 will attempt to make a run at a record high this week, I’m worried about the Nasdaq – they both will scare markets as ANY new record becomes attainable?

The Dow jumped +0.7% and the S&P 500 advanced +0.6%, on the week for their second (2nd) straight positive week; while the Nasdaq gained just shy of 0.5% this week for its third (3rd) winning week in a row.

 

RegMed/Cell and Gene Therapy Earnings Scorecard Q1/21 LPS Results … thirty (32 – MESO added) to date …  https://www.regmedinvestors.com/articles/11628

 

Friday’s evening’s recap: “depths and peaks as experienced by the week” … https://www.regmedinvestors.com/articles/11942

  • The Nasdaq closed UP +199.98 points (+1.47%);
  • The IBB closed up +1.42% and XBI closed down -0.00%;
  • Sector volume was LOW with 3 of the 25-upside having higher than the 3-month average volume with the volume of 0 of 8-downside having higher than the 3-month average volume;
  • The CBOE Volatility Index (VVIX: INDEX) was down -1.62 points or -8.98% at 16.42;
  • Friday’s percentage (%) of the 25-upside were +0.25% (AGTC) to +17.12% (BSTG) while the 8-downside ranges from -0.28% (BCLI) to -2.31% (RARE);

Q2/21:

June: 2 positive and 2 negative close

May:  8 positive, 12 negative closes and 1 holiday

April: 11 negative and 10 positive closes

Q1/21:

  • March: 10 positive, 12 negative and 1 neutral closes
  • February: 9 positive, 10 negative closes and 1 holiday
  • January: 10 positive, 9 negative closes and 1 holiday

 

Companies in my headlights – It’s your decision; I provide an idea and context:

The Biostage (BSTG) - Maintaining Sell – It’s about saying WHAT NEEDS to be written …

Biostage (BSTG) closed up +$0.19 to $1.30 with 800 shares traded after Thursday’s flat with 3,528 shares traded, Wednesday’s -0.11 to $1.11 with 5,673 shares traded, Tuesday’s +$0.10 to $1.22 with 2216 shares traded post Monday’s holiday.

Question#`1: Notice the volume numbers per session? WHY the need to “pump, promote and inflate” the share price; does the volume reflects the manipulation to execute the last remaining warrants?

MINORITY PUBLIC shareholders are waiting, watching and weighing responses to MAINTAIN their RIGHTS.

 

More morning’s indications:

BUY:

bluebird bio (BLUE) closed up +$0.22 to $30.92 and has a positive +$0.38 or +1.23% aftermarket (Friday) indication.

CRISPR Therapeutics (CRSP) closed up +$3.16 to $113.29 and has a positive +$0.61 or +0.54% pre-market

Editas Medicine (EDIT) closed up +$0.51 to $33.67 and has a positive +$0.32 or +0.95% aftermarket (Friday) indication.

uniQure NV (QURE) closed up +$0.45 to $35.32 and has a positive +$0.28 or +o.79% aftermarket (Friday) indication.

Sage Therapeutics (SAGE) closed up +$1.05 to $67.61 and has a positive +$2.80% aftermarket (Friday) indication.

 

SELL:

Homology Medicine (FIXX) closed down -$0.02 to $6.53 and has a negative -$0.23 or -3.52% aftermarket (Friday) indication.

Global Blood therapeutics (GBT) closed up +$0.74 to $39.00 and has a negative -$0.47 or -$1.21% aftermarket (Friday) indication.

 

The BOTTOM LINE: Wake-up volatility is NOT going away!

I continue to MAINTAIN, this is a confused sector as sentiment fades, momentum is usurped, fundamentals are being ignored – or is it a test of our staying power in certain equities.

It’s going be a long hot summer – expects the fizzle on stock pricing until it isn’t!

Although, “I would consider new highs … to be SOLD into …complacency is in store as many investors actually get out to vacations (one indicator).”

A true contrarian thought …

My focus has always been “warning analysis” … my advice, trim and skim any new highs if one can!” I also see a number of lows that could be in the “pick-up” stock game.

My motto, never leave an investor uninformed about what I know!

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.